Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
3.000
+0.050 (1.69%)
May 8, 2025, 4:00 PM - Market closed
Relay Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Revenue | 7.68 | 10.01 | 25.55 | 1.38 | 3.03 | 82.65 | Upgrade
|
| Revenue Growth (YoY) | -78.26% | -60.83% | 1749.82% | -54.41% | -96.34% | - | Upgrade
|
| Cost of Revenue | 306.85 | 315.44 | 326.39 | 243.01 | 169.39 | 96.59 | Upgrade
|
| Gross Profit | -299.17 | -305.43 | -300.84 | -241.62 | -166.36 | -13.94 | Upgrade
|
| Selling, General & Admin | 79.18 | 80.24 | 78.58 | 69.33 | 59.75 | 41.86 | Upgrade
|
| Operating Expenses | 79.18 | 80.24 | 78.58 | 69.33 | 59.75 | 41.86 | Upgrade
|
| Operating Income | -378.35 | -385.67 | -379.42 | -310.95 | -226.11 | -55.8 | Upgrade
|
| Interest & Investment Income | 33.61 | 34.75 | 31.05 | 8.79 | 0.83 | 3.4 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.02 | 0.01 | -0.02 | -0.02 | -0 | -0.02 | Upgrade
|
| EBT Excluding Unusual Items | -344.76 | -350.91 | -348.4 | -302.19 | -225.28 | -52.41 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -0.9 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | -11.86 | - | Upgrade
|
| Other Unusual Items | 11.37 | 13.21 | 6.42 | 11.68 | -2.84 | - | Upgrade
|
| Pretax Income | -333.39 | -337.71 | -341.97 | -290.51 | -363.87 | -52.41 | Upgrade
|
| Net Income | -333.39 | -337.71 | -341.97 | -290.51 | -363.87 | -52.41 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 177.79 | Upgrade
|
| Net Income to Common | -333.39 | -337.71 | -341.97 | -290.51 | -363.87 | -230.2 | Upgrade
|
| Shares Outstanding (Basic) | 152 | 143 | 123 | 112 | 95 | 43 | Upgrade
|
| Shares Outstanding (Diluted) | 152 | 143 | 123 | 112 | 95 | 43 | Upgrade
|
| Shares Change (YoY) | 22.01% | 16.55% | 9.21% | 17.97% | 123.22% | 1135.17% | Upgrade
|
| EPS (Basic) | -2.19 | -2.36 | -2.79 | -2.59 | -3.82 | -5.40 | Upgrade
|
| EPS (Diluted) | -2.19 | -2.36 | -2.79 | -2.59 | -3.82 | -5.40 | Upgrade
|
| Free Cash Flow | -272.62 | -251.13 | -304.44 | -238.55 | -77.88 | -104.42 | Upgrade
|
| Free Cash Flow Per Share | -1.79 | -1.76 | -2.48 | -2.13 | -0.82 | -2.45 | Upgrade
|
| Gross Margin | - | - | - | - | - | -16.86% | Upgrade
|
| Operating Margin | -4927.05% | -3854.04% | -1485.25% | -22516.44% | -7464.74% | -67.51% | Upgrade
|
| Profit Margin | -4341.53% | -3374.72% | -1338.66% | -21036.13% | -12012.94% | -278.51% | Upgrade
|
| Free Cash Flow Margin | -3550.15% | -2509.49% | -1191.74% | -17273.86% | -2571.05% | -126.33% | Upgrade
|
| EBITDA | -373.07 | -380.21 | -374.15 | -306.82 | -222.18 | -52.25 | Upgrade
|
| EBITDA Margin | - | - | - | - | - | -63.21% | Upgrade
|
| D&A For EBITDA | 5.28 | 5.46 | 5.27 | 4.13 | 3.93 | 3.55 | Upgrade
|
| EBIT | -378.35 | -385.67 | -379.42 | -310.95 | -226.11 | -55.8 | Upgrade
|
| EBIT Margin | - | - | - | - | - | -67.51% | Upgrade
|
| Revenue as Reported | 7.68 | 10.01 | 25.55 | 1.38 | 3.03 | 82.65 | Upgrade
|
Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.